{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:25:44Z","timestamp":1792106744783,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,26]]},"DOI":"10.7759\/cureus.29583","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T08:32:02Z","timestamp":1664181122000},"source":"Crossref","is-referenced-by-count":61,"title":["Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment"],"prefix":"10.7759","author":[{"given":"Hrishikesh","family":"Vyawahare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranaykumar","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.02.009","article-title":"Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","volume":"9","author":"Deng Y","year":"2022","unstructured":"Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L. Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2022, 9:62-79. 10.1016\/j.gendis.2021.02.009","journal-title":"Genes Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01503-3","article-title":"AI-based structure-function correlation in age-related macular degeneration","volume":"35","author":"von der Emde L","year":"2021","unstructured":"von der Emde L, Pfau M, Holz FG, et al.. AI-based structure-function correlation in age-related macular degeneration. Eye (Lond). 2021, 35:2110-8. 10.1038\/s41433-021-01503-3","journal-title":"Eye (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S231913","article-title":"Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options","volume":"16","author":"Tan CS","year":"2022","unstructured":"Tan CS, Ngo WK, Chay IW, Ting DS, Sadda SR. Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options. Clin Ophthalmol. 2022, 16:917-33. 10.2147\/OPTH.S231913","journal-title":"Clin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153297","article-title":"Prevention of the onset of age-related macular degeneration","volume":"10","author":"Di Carlo E","year":"2021","unstructured":"Di Carlo E, Augustin AJ. Prevention of the onset of age-related macular degeneration. J Clin Med. 2021, 10:3297. 10.3390\/jcm10153297","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173993","article-title":"Peripheral manifestations in age related macular degeneration: a review of imaging and findings","volume":"10","author":"Pivovar A","year":"2021","unstructured":"Pivovar A, Oellers P. Peripheral manifestations in age related macular degeneration: a review of imaging and findings. J Clin Med. 2021, 10:10.3390\/jcm10173993","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-016-0063-5","article-title":"Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors","volume":"3","author":"Pennington KL","year":"2016","unstructured":"Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016, 3:34. 10.1186\/s40662-016-0063-5","journal-title":"Eye Vis (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2021.08.011","article-title":"Global burden of dry age-related macular degeneration: a targeted literature review","volume":"43","author":"Schultz NM","year":"2021","unstructured":"Schultz NM, Bhardwaj S, Barclay C, Gaspar L, Schwartz J. Global burden of dry age-related macular degeneration: a targeted literature review. Clin Ther. 2021, 43:1792-818. 10.1016\/j.clinthera.2021.08.011","journal-title":"Clin Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2147-8","article-title":"Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen A","year":"2016","unstructured":"Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016, 73:1765-86. 10.1007\/s00018-016-2147-8","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-016-0234-z","article-title":"An eye on age-related macular degeneration: the role of microRNAs in disease pathology","volume":"21","author":"Berber P","year":"2017","unstructured":"Berber P, Grassmann F, Kiel C, Weber BH. An eye on age-related macular degeneration: the role of microRNAs in disease pathology. Mol Diagn Ther. 2017, 21:31-43. 10.1007\/s40291-016-0234-z","journal-title":"Mol Diagn Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052592","article-title":"Exudative versus nonexudative age-related macular degeneration: physiopathology and treatment options","volume":"23","author":"Fernandes AR","year":"2022","unstructured":"Fernandes AR, Zieli\u0144ska A, Sanchez-Lopez E, et al.. Exudative versus nonexudative age-related macular degeneration: physiopathology and treatment options. Int J Mol Sci. 2022, 23:10.3390\/ijms23052592","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2913612","article-title":"Cellular and molecular pathology of age-related macular degeneration: potential role for proteoglycans","volume":"2016","author":"Al Gwairi O","year":"2016","unstructured":"Al Gwairi O, Thach L, Zheng W, Osman N, Little PJ. Cellular and molecular pathology of age-related macular degeneration: potential role for proteoglycans. J Ophthalmol. 2016, 2016:2913612. 10.1155\/2016\/2913612","journal-title":"J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9945725","article-title":"Complement inhibitors in age-related macular degeneration: a potential therapeutic option","volume":"2021","author":"Qin S","year":"2021","unstructured":"Qin S, Dong N, Yang M, Wang J, Feng X, Wang Y. Complement inhibitors in age-related macular degeneration: a potential therapeutic option. J Immunol Res. 2021, 2021:9945725. 10.1155\/2021\/9945725","journal-title":"J Immunol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111837","article-title":"Medication trends for age-related macular degeneration","volume":"22","author":"Cho YK","year":"2021","unstructured":"Cho YK, Park DH, Jeon IC. Medication trends for age-related macular degeneration. Int J Mol Sci. 2021, 22:10.3390\/ijms222111837","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13949","article-title":"Neovascular age-related macular degeneration: a review of findings from the real-world Fight Retinal Blindness! registry","volume":"49","author":"Nguyen V","year":"2021","unstructured":"Nguyen V, Barthelmes D, Gillies MC. Neovascular age-related macular degeneration: a review of findings from the real-world Fight Retinal Blindness! registry. Clin Exp Ophthalmol. 2021, 49:652-63. 10.1111\/ceo.13949","journal-title":"Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910594","article-title":"Ocular therapeutics and molecular delivery strategies for neovascular age-related macular degeneration (nAMD)","volume":"22","author":"Sarkar A","year":"2021","unstructured":"Sarkar A, Junnuthula V, Dyawanapelly S. Ocular therapeutics and molecular delivery strategies for neovascular age-related macular degeneration (nAMD). Int J Mol Sci. 2021, 22:10.3390\/ijms221910594","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000524942","article-title":"Pathophysiology of age-related macular degeneration. Implications for treatment","author":"Garcia-Garcia J","year":"2022","unstructured":"Garcia-Garcia J, Usategui-Martin R, Sanabria MR, Fernandez-Perez E, Telleria JJ, Coco-Martin RM. Pathophysiology of age-related macular degeneration. Implications for treatment. Ophthalmic Res. 2022, 10.1159\/000524942","journal-title":"Ophthalmic Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00325-5","article-title":"Pipeline therapies for neovascular age related macular degeneration","volume":"7","author":"Arepalli S","year":"2021","unstructured":"Arepalli S, Kaiser PK. Pipeline therapies for neovascular age related macular degeneration. Int J Retina Vitreous. 2021, 7:55. 10.1186\/s40942-021-00325-5","journal-title":"Int J Retina Vitreous"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S205147","article-title":"Predictors of visual acuity after treatment of neovascular age-related macular degeneration - current perspectives","volume":"15","author":"Phan LT","year":"2021","unstructured":"Phan LT, Broadhead GK, Hong TH, Chang AA. Predictors of visual acuity after treatment of neovascular age-related macular degeneration - current perspectives. Clin Ophthalmol. 2021, 15:3351-67. 10.2147\/OPTH.S205147","journal-title":"Clin Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111161","article-title":"Quantitative imaging biomarkers in age-related macular degeneration and diabetic eye disease: a step closer to precision medicine","volume":"11","author":"Kalra G","year":"2021","unstructured":"Kalra G, Kar SS, Sevgi DD, Madabhushi A, Srivastava SK, Ehlers JP. Quantitative imaging biomarkers in age-related macular degeneration and diabetic eye disease: a step closer to precision medicine. J Pers Med. 2021, 11:10.3390\/jpm11111161","journal-title":"J Pers Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092414","article-title":"Regulation of Rac1 activation in choroidal endothelial cells: insights into mechanisms in age-related macular degeneration","volume":"10","author":"Ramshekar A","year":"2021","unstructured":"Ramshekar A, Wang H, Hartnett ME. Regulation of Rac1 activation in choroidal endothelial cells: insights into mechanisms in age-related macular degeneration. Cells. 2021, 10:10.3390\/cells10092414","journal-title":"Cells"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168387","article-title":"Retinal pigment epithelium expressed toll-like receptors and their potential role in age-related macular degeneration","volume":"22","author":"Klettner A","year":"2021","unstructured":"Klettner A, Roider J. Retinal pigment epithelium expressed toll-like receptors and their potential role in age-related macular degeneration. Int J Mol Sci. 2021, 22:10.3390\/ijms22168387","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/life12010036","article-title":"Retinal progression biomarkers of early and intermediate age-related macular degeneration","volume":"12","author":"Flores R","year":"2021","unstructured":"Flores R, Carneiro \u00c2, Tenreiro S, Seabra MC. Retinal progression biomarkers of early and intermediate age-related macular degeneration. Life (Basel). 2021, 12:10.3390\/life12010036","journal-title":"Life (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01487-0","article-title":"Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations","volume":"35","author":"Kodjikian L","year":"2021","unstructured":"Kodjikian L, Parravano M, Clemens A, et al.. Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations. Eye (Lond). 2021, 35:2119-35. 10.1038\/s41433-021-01487-0","journal-title":"Eye (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211031547","article-title":"Imaging and artificial intelligence for progression of age-related macular degeneration","volume":"246","author":"Romond K","year":"2021","unstructured":"Romond K, Alam M, Kravets S, et al.. Imaging and artificial intelligence for progression of age-related macular degeneration. Exp Biol Med (Maywood). 2021, 246:2159-69. 10.1177\/15353702211031547","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318452","article-title":"Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions","volume":"106","author":"Cabral de Guimaraes TA","year":"2022","unstructured":"Cabral de Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions. Br J Ophthalmol. 2022, 106:297-304. 10.1136\/bjophthalmol-2020-318452","journal-title":"Br J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122035","article-title":"Nanotechnology for age-related macular degeneration","volume":"13","author":"Yang B","year":"2021","unstructured":"Yang B, Li G, Liu J, Li X, Zhang S, Sun F, Liu W. Nanotechnology for age-related macular degeneration. Pharmaceutics. 2021, 13:10.3390\/pharmaceutics13122035","journal-title":"Pharmaceutics"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S272327","article-title":"Photobiomodulation therapy for age-related macular degeneration and diabetic retinopathy: a review","volume":"15","author":"Muste JC","year":"2021","unstructured":"Muste JC, Russell MW, Singh RP. Photobiomodulation therapy for age-related macular degeneration and diabetic retinopathy: a review. Clin Ophthalmol. 2021, 15:3709-20. 10.2147\/OPTH.S272327","journal-title":"Clin Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2021.08.20","article-title":"Newly-found functions of metformin for the prevention and treatment of age-related macular degeneration","volume":"14","author":"Dang KR","year":"2021","unstructured":"Dang KR, Wu T, Hui YN, Du HJ. Newly-found functions of metformin for the prevention and treatment of age-related macular degeneration. Int J Ophthalmol. 2021, 14:1274-80. 10.18240\/ijo.2021.08.20","journal-title":"Int J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317434","article-title":"Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence","volume":"105","author":"Daien V","year":"2021","unstructured":"Daien V, Finger RP, Talks JS, et al.. Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence. Br J Ophthalmol. 2021, 105:1475-9. 10.1136\/bjophthalmol-2020-317434","journal-title":"Br J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081255","article-title":"A systematic review of carotenoids in the management of age-related macular degeneration","volume":"10","author":"Lem DW","year":"2021","unstructured":"Lem DW, Davey PG, Gierhart DL, Rosen RB. A systematic review of carotenoids in the management of age-related macular degeneration. Antioxidants (Basel). 2021, 10:10.3390\/antiox10081255","journal-title":"Antioxidants (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2022.01.23","article-title":"Progress of clinical therapies for dry age-related macular degeneration","volume":"15","author":"Rubner R","year":"2022","unstructured":"Rubner R, Li KV, Canto-Soler MV. Progress of clinical therapies for dry age-related macular degeneration. Int J Ophthalmol. 2022, 15:157-66. 10.18240\/ijo.2022.01.23","journal-title":"Int J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020325","article-title":"Managing neovascular age-related macular degeneration in clinical practice: systematic review, meta-analysis, and meta-regression","volume":"11","author":"Veritti D","year":"2022","unstructured":"Veritti D, Sarao V, Soppelsa V, Danese C, Chhablani J, Lanzetta P. Managing neovascular age-related macular degeneration in clinical practice: systematic review, meta-analysis, and meta-regression. J Clin Med. 2022, 11:10.3390\/jcm11020325","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02894-0","article-title":"Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration","volume":"13","author":"Dehghan S","year":"2022","unstructured":"Dehghan S, Mirshahi R, Shoae-Hassani A, Naseripour M. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration. Stem Cell Res Ther. 2022, 13:217. 10.1186\/s13287-022-02894-0","journal-title":"Stem Cell Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109204-age-related-macular-degeneration-epidemiology-pathophysiology-diagnosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:26Z","timestamp":1707508106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109204-age-related-macular-degeneration-epidemiology-pathophysiology-diagnosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.29583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,26]]}}}